Investigating circulating tumor cells in cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on the collection and analysis of circulating tumor cells (CTCs) from blood samples of adult cancer patients at various stages of their disease. It aims to understand the biology of CTCs and their clusters, evaluating their potential as biomarkers for cancer progression and overall survival. The study will also explore key signaling networks active in CTCs across different cancer types, providing insights into their role in cancer biology.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult cancer patients
* All patients with histology-based proved diagnosis of cancer, all stages and subtypes can be included. Precancerous lesions cannot be included.
* All patients with the diagnosis of a solid tumor including adenocarcinoma, squamous cell carcinoma, neuroendocrine carcinoma, sarcoma
* Written pathology report must be available.
* Written informed consent.

Exclusion Criteria:

* No written informed consent.
* No proved diagnosis of malignancy by pathology report.
* Patients with the diagnosis of blood cancer

Where it's running

• University Hospital Basel
  Basel, Switzerland Recruiting
• Department Oncology, Haematology & Immuntherapy, Kantonsspital Baselland
  Liestal, Switzerland Recruiting

Study contacts

• Principal investigator: Marcus Vetter, PD Dr. med. — Kantonsspital Baselland, Liestal
• Study coordinator: Marcus Vetter, PD Dr. med.
• Email: marcus.vetter@ksbl.ch
• Phone: +41 61 925 27 15

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Predicting bowel leaks after colorectal surgery with a computer model and surgeon input

  This study tests a computer model that predicts anastomotic leaks after colorectal surgery, and sees if adding surgeons’ intuition improves the predictions.

  Recruiting at 2 sites University Hospital, Basel, Switzerland · Liestal, Basel-Landschaft and 1 other locations · NCT07888478

• Active surveillance after immunotherapy for MMR-deficient colorectal and GI cancers

  This study looks at whether some patients with non-metastatic, MMR-deficient or MSI-H colorectal cancers can skip surgery after a strong response to immunotherapy.

  Recruiting at 3 sites University Hospital, Basel, Switzerland · Basel and 2 other locations · NCT07829081

• PCI Registry at University Hospital Basel for Complex Coronary Procedures

  This registry collects real-world data from adults undergoing percutaneous coronary interventions at University Hospital Basel to see how different treatments like drug-eluting stents, drug-coated balloons, and bioresorbable scaffolds perform in diverse patients.

  Recruiting University Hospital, Basel, Switzerland · Basel, Canton of Basel-City · NCT07814157

• Severe Complications During VT/PVC Ablation

  This study looks at real-world cases to see what severe complications occur during VT or PVC ablations and how patients are managed afterward.

  Recruiting at 25 sites University Hospital, Basel, Switzerland · Chicago, Illinois and 24 other locations · NCT07777744

• Visioning III: Five-year follow-up for MRI-based prostate cancer screening

  This study tests a repeat MRI-based screening approach for men who previously had no cancer signs, to see if a negative bpMRI reliably predicts no significant cancer for at least five years.

  Recruiting University Hospital, Basel, Switzerland · Basel, Canton of Basel-City · NCT07762911

• Oxytocin in postmenopausal and premenopausal women

  Researchers will test whether cumulative endogenous neurophysin I, a surrogate for oxytocin, differs over a month between premenopausal and postmenopausal women.

  Recruiting University Hospital, Basel, Switzerland · Basel, Canton of Basel-City · NCT07742124

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.